Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
Clinical trial NCT03768726 · TERMINATED
Trial details
- NCT number
- NCT03768726
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2020-07-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.